B01診斷與監測用醫材

瀚源生醫創立於2016年，致力於發展應用導向、具高靈敏度的BioFET平台，即時監測健康狀態，以提供精準醫療所需的資訊。瀚源生醫的平台可有效應用於收集基因變異及蛋白質表現異常等資訊，來建立針對生物分子調控之動態檢測，幫助監測與診斷複雜的疾病。 Founded in 2016, Helios Bioelectronics, Inc. is developing an application-driven and highly sensitive BioFET platform, enabling real-time monitoring of health status for precision medicine.  The platform serves to collect information such as biologically significant genetic aberrations and altered protein expressions to establish dynamic profiling of the molecular regulations for monitoring and diagnostics of complex diseases.

瀚源生醫的BioFET平台可檢測任何具電性差異的標的物，包含蛋白質、細菌、核酸（如miRNA）和細胞等生物標的物。我們能在BioFET晶片上，客製化地固定上針對特定標的的探針。此生物晶片不僅可以減少樣品準備的步驟，檢測標的亦不需額外的標記，因此能大幅度地縮短檢測時間。此外，在一個指尖大小晶片上，可以容納超過一百萬個生物感測器，使得一個BioFET晶片可以同時檢測多個種類的生物標的，同時具有高度統計效益。 Helios BioFET platform can detect any targets with a net charge, including protein, bacteria, nucleic acid (e.g. miRNA), cell and so on.  The BioFET chips are readily customizable by immobilizing target-specific probes onto the chip surface.  Hence, minimal sample preparation is needed and no labeling is necessary for target detection.  In addition, over one million biosensors can fit into the size of a fingertip, allowing for detection of multiple targets on a single BioFET chip with significant statistical power. BioFET chips generate data that can be readily digitized and transmitted through Cloud computing for AI analysis. Together with the portable-size equipment, Helios aims to take up the rapid growing markets of POCT and molecular diagnostics for personalized and decentralized digital healthcare.